Metropolis Healthcare shares are trading lower on higher volumes. Credit Suisse noted that the company’s stock is expensive despite correction. The company reported a 30% YoY fall in Q3 net profit reported on February 11.
Metropolis Healthcare is one of the leading diagnostics companies in India by revenue. Through widespread operational network, the company offers a comprehensive range of clinical laboratory tests and profiles, which are used to predict early detection, diagnostic screening, confirmation and/or monitoring of the disease. It also offers analytical and support services to clinical research organizations for their clinical research projects. The company conducts its operations through a laboratory and service network.
View Price, OI, Greeks and more...
| Day | Open | Close | Day's change |
|---|---|---|---|
| Fri, Jan 27 | 1,299.10 | 1,300.90 | 0.14% |
| Wed, Jan 25 | 1,310.00 | 1,298.60 | -0.88% |
| Tue, Jan 24 | 1,328.00 | 1,308.70 | -1.47% |
| Mon, Jan 23 | 1,312.00 | 1,323.35 | 0.86% |
| Fri, Jan 20 | 1,361.20 | 1,309.75 | -3.93% |
| Thu, Jan 19 | 1,374.15 | 1,357.95 | -1.19% |
| Wed, Jan 18 | 1,392.35 | 1,374.15 | -1.32% |
On Mutual Fund and IPOs
On Equity Delivery orders
On Equity Intraday, F&O, Commodity and Currency orders
On Mutual Fund and IPOs
On Equity Delivery orders
On Equity Intraday, F&O, Commodity and Currency orders
Healthcare Services 
